We welcome the Rhenus Group as a full member and KatalX as an associate partner in our organization and look forward to a close collaboration on current and future projects.
The Rhenus Group is one of the leading logistics specialists with global business operations and an annual turnover amounting to EUR 7.0 billion. 37,500 employees work at 970 business sites and develop innovative solutions along the complete supply chain.
KatalX is a Supply Chain Visibility Platform that focuses on Life Science and MedTech end-to-end supply chain.
Frank Van Gelder, Secretary General of Pharma.Aero: “With onboarding Rhenus, with a clear and determined Life Science and MedTech vision multi-modal, we are enlarging the group of driven full members, that collaborate beyond their own programs to ensure the overall improvement of the industry.
As we drive innovation and engage new projects on the next generation technologies, our new associate partner KatalX matches our common ambition in collaboration and visibility through advanced digital analytics.”
Stephan Dülk, Global Head of Life Sciences and Healthcare at Rhenus Air & Ocean: “Joining Pharma.Aero provides a great platform and visibility for Rhenus to collaborate with the different stakeholders in the life sciences & healthcare supply chain and to share, learn and grow in this segment. It is a privilege to be part of a global community like Pharma.Aero, working towards continuously improving the standards and defining customer end-to-end solutions across all related fields and business markets. The platform allows us to align with Rhenus global life sciences and healthcare strategy and our vision that it is all about patient safety.”
Damien de Chillaz, CEO and Co-Founder of KatalX: “We created KatalX to bridge the visibility and collaboration gaps in supply chains, starting with vital ones where real-time control end-to-end is absolutely mission critical. We see this as a foundation for Trust, hence our mission: Catalyzing Trust in Supply Chains.
We are truly honoured to join Pharma.Aero and have been inspired by its cross-industry leadership from the very early days of KatalX, at the time of Project Sunrays and the challenges of Covid-19 Vaccine logistics. We really look forward to engaging with members and associate partners on projects like Cell & Gene Therapy, Vaccine distribution and Sustainability. “
With onboarding Rhenus Group and KatalX, our organization’s network grows to 48 members, and associate partners from 6 continents.
